
Welcome to this Biomolecules webinar, entitled “Perineural Invasion in Pancreatic Cancer: From Biology to Translational and Clinical Perspectives.” Perineural invasion is a key feature of pancreatic cancer and reflects complex interactions among tumor cells, nerves, and the tumor microenvironment. Our speakers will address biological, translational, and clinical perspectives, followed by a consolidated Q&A. I am pleased to welcome Prof. Ihsan Ekin Demir, Prof. Elisa Giovannetti, and Prof. Pinar Uysal-Onganer.
Date: 26 November 2026
Time: 2:00 pm CET | 9:00 am EDT
Webinar ID: 815 0453 0803
Webinar Secretariat: journal.webinar@mdpi.com

Medical Oncology Unit, University Hospital of Parma, Parma, Italy;Ingrid Garajová, MD, PhD, is a medical oncologist and researcher at the University Hospital of Parma, Italy. She leads the EORTC Pancreatic Cancer Task Force and is also a member of the EORTC-PAMM Board and an elected member of the Oncology Task Force of AISP (Italian Association for the Study of the Pancreas). Her clinical and scientific work focuses mainly on pancreatic cancer, and she is actively involved in international clinical and translational research collaborations. Moreover, she was awarded an EORTC research grant for a project investigating perineural invasion in pancreatic cancer.
Department of Surgery, Technical University of Munich, Munich, Germany;Prof. Dr. Ihsan Ekin Demir is a surgeon and researcher at the Department of Surgery, Technical University of Munich, Munich, Germany. He leads the Pancreas Research Laboratory and focuses on pancreatic cancer, cancer neuroscience, and the interaction between the nervous system and tumor biology. His work combines pancreatic surgery with translational research, particularly in neuro-invasive mechanisms and the tumor microenvironment.
Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands and AIRC Start-Up Unit ;Fondazione Pisana per la Scienza, Pisa, Italy;Prof. Elisa Giovannetti is a clinical pharmacologist and translational cancer researcher with a major focus on pancreatic and thoracic cancers. Her research investigates mechanisms of drug resistance, biomarkers of treatment response, pharmacogenetics, and novel therapeutic combinations integrating chemotherapy, targeted therapy, and immunotherapy. She leads a multidisciplinary Cancer Pharmacology Laboratory and has developed preclinical platforms to study drug activity in pancreatic cancer. She is Full Professor-qualified in Pharmacology in Italy and serves as elected Chair of the EORTC-PAMM group, with extensive involvement in international research networks and collaborative projects.
School of Life Sciences, Cancer Mechanisms and Biomarkers Group, The University of Westminster, United Kingdom.;Prof. Pinar Uysal-Onganer is Professor of cellular and molecular biology at the University of Westminster, London, and leads the Cancer Mechanisms and Biomarkers Research Group. Her research focuses on cancer progression, metastasis and therapy resistance, with particular interest in pancreatic cancer, non-coding RNAs, epigenetic regulation, tumor microenvironmental stress and liquid biopsy biomarkers. Her work integrates molecular oncology and translational research to identify biomarkers for early detection, prognosis and therapeutic stratification.
|
Speaker/Presentation |
Time In EDT |
Time In CET |
|
Dr. Ingrid Garajova |
8:00 - 8:05 |
14:00 - 14:05 |
|
Prof. Dr. Ihsan Ekin Demir |
8:05 - 8:20 |
14:05 - 14:20 |
|
Dr. Elisa Giovannetti |
8:20 - 8:35 |
14:20 - 14:35 |
|
Prof. Dr. Pinar Uysal-Onganer |
8:35 - 8:50 |
14:35 - 14:50 |
|
Q&A Session |
8:50 - 8:58 |
14:50 - 14:58 |
|
Closing of Webinar |
8:58 - 9:00 |
14:58 - 15:00 |